Literature DB >> 18536866

Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy.

Kevin Damman, Rudolf A de Boer, Dirk J van Veldhuisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18536866     DOI： 10.1007/s00392-008-0680-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  21 in total

Review 1.  [Drug treatment of chronic heart failure].

Authors:  M Böhm; N Werner; M Kindermann
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

2.  Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.

Authors:  Istvan Edes; Zbigniew Gasior; Krystian Wita
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

3.  Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.

Authors:  Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip Poole-Wilson; Claude Le Pen
Journal:  Eur Heart J       Date:  2005-04-12       Impact factor: 29.983

4.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

5.  Rosuvastatin in older patients with systolic heart failure.

Authors:  John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Assen Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; John J V McMurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

Authors:  Finlay A McAlister; Justin Ezekowitz; Marcello Tonelli; Paul W Armstrong
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

7.  Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

Authors:  Hans-Dirk Düngen; Svetlana Apostolović; Simone Inkrot; Elvis Tahirović; Florian Krackhardt; Milan Pavlović; Biljana Putniković; Mitja Lainscak; Götz Gelbrich; Frank Edelmann; Rolf Wachter; Thomas Eschenhagen; Finn Waagstein; Ferenc Follath; Mathias Rauchhaus; Wilhelm Haverkamp; Karl-Josef Osterziel; Rainer Dietz
Journal:  Clin Res Cardiol       Date:  2008-06-09       Impact factor: 5.460

8.  Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.

Authors:  H L Hillege; W H van Gilst; D J van Veldhuisen; G Navis; D E Grobbee; P A de Graeff; D de Zeeuw
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.

Authors:  F Peters-Klimm; T Müller-Tasch; D Schellberg; A Remppis; A Barth; N Holzapfel; J Jünger; W Herzog; J Szecsenyi
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

10.  Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

Authors:  Tiny Jaarsma; Martje H L van der Wal; Ivonne Lesman-Leegte; Marie-Louise Luttik; Jochem Hogenhuis; Nic J Veeger; Robbert Sanderman; Arno W Hoes; Wiek H van Gilst; Dirk J A Lok; Peter H J M Dunselman; Jan G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
Journal:  Arch Intern Med       Date:  2008-02-11
View more
  2 in total

1.  Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.

Authors:  Martin C S Wong; Johnny Y Jiang; Xuefen Su; Haoxiang Wang; Jin Ling Tang; Sian M Griffiths
Journal:  Clin Res Cardiol       Date:  2010-02-21       Impact factor: 5.460

2.  Ivabradine for the treatment of stable angina pectoris in octogenarians.

Authors:  Ralf Koester; Jan Kaehler; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2010-09-06       Impact factor: 5.460
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.